BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7702987)

  • 1. Multidrug resistance in lung cancer.
    Broxterman HJ; Versantvoort CH; Linn SC
    Cancer Treat Res; 1995; 72():193-222. PubMed ID: 7702987
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of multidrug resistance.
    Herzog CE; Bates SE
    Cancer Treat Res; 1994; 73():129-47. PubMed ID: 7710903
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
    Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
    Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting multidrug resistance to treat cancer.
    Gottesman MM; Ambudkar SV; Ni B; Aran JM; Sugimoto Y; Cardarelli CO; Pastan I
    Cold Spring Harb Symp Quant Biol; 1994; 59():677-83. PubMed ID: 7587130
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of gene amplification in drug resistance.
    Schoenlein PV
    Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.
    Heenan M; O'Driscoll L; Cleary I; Connolly L; Clynes M
    Int J Cancer; 1997 May; 71(5):907-15. PubMed ID: 9180164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single doses of irradiation on the expression of resistance-related proteins in murine NIH 3T3 and human lung carcinoma cells.
    Stammler G; Pommerenke EW; Mattern J; Volm M
    Carcinogenesis; 1995 Sep; 16(9):2051-5. PubMed ID: 7554053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro models for testing of cytostatic agents in small cell lung cancer.
    Jensen PB; Sehested M
    Cancer Treat Res; 1995; 72():171-91. PubMed ID: 7702986
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unanswered questions about multidrug resistance.
    Beck WT
    Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance mechanisms and their regulation in lung cancer.
    Volm M; Mattern J
    Crit Rev Oncog; 1996; 7(3-4):227-44. PubMed ID: 9258604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of drug resistance.
    Biedler JL; Spengler BA
    Cancer Treat Res; 1994; 73():1-16. PubMed ID: 7710901
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
    Withoff S; de Vries EG; Keith WN; Nienhuis EF; van der Graaf WT; Uges DR; Mulder NH
    Br J Cancer; 1996 Dec; 74(12):1869-76. PubMed ID: 8980384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; DurĂ¡n GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein and multidrug resistance.
    Gottesman MM; Pastan I; Ambudkar SV
    Curr Opin Genet Dev; 1996 Oct; 6(5):610-7. PubMed ID: 8939727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of P-glycoprotein in normal and malignant rat liver cells.
    Lee CH; Bradley G; Ling V
    Cold Spring Harb Symp Quant Biol; 1994; 59():607-15. PubMed ID: 7587120
    [No Abstract]   [Full Text] [Related]  

  • 19. A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues.
    Schwarzenbach H
    Anal Biochem; 2002 Sep; 308(1):26-33. PubMed ID: 12234460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.